[The extrahepatic manifestations in hepatitis C virus (HCV) infection]

Vutreshni Bolesti
|June 10, 2000
PubMed

Insights

Hepatitis C virus (HCV) infection impacts more than the liver, causing numerous extrahepatic lesions. Understanding these diverse manifestations is crucial for effective treatment strategies.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Context:

  • Hepatitis C virus (HCV) infection is increasingly recognized for its systemic effects beyond the liver.
  • Extrahepatic manifestations (EHMs) associated with HCV are diverse and numerous.
  • Established links exist between HCV and conditions like mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and porphyria cutanea tarda.

Purpose:

  • To explore the expanding range of extrahepatic lesions associated with Hepatitis C virus (HCV) infection.
  • To discuss the potential pathogenetic mechanisms, including immune system involvement and viral replication, underlying HCV-related EHMs.
  • To highlight the therapeutic challenges posed by the poorly understood mechanisms of HCV EHMs.

Summary:

  • HCV infection affects multiple organs and systems, leading to a growing list of documented extrahepatic lesions.
  • Confirmed associations include mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and porphyria cutanea tarda.
  • HCV's role in thyroid disease, Sjögren's syndrome, lichen planus, diabetes, and antiphospholipid syndrome is under investigation.
  • Pathogenesis may involve immune dysregulation or direct viral activity in affected tissues.
  • Unclear mechanisms complicate treatment choices, particularly regarding interferon and corticosteroids.

Impact:

  • This research underscores the systemic nature of HCV infection, necessitating a broader clinical perspective.
  • It emphasizes the need for further research into the pathogenesis of HCV-related extrahepatic manifestations.
  • Improved understanding of these mechanisms could lead to more targeted and effective therapeutic interventions for HCV patients.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...